These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 3138966
1. The efficiency of specific immunization with corpuscular vaccines in the treatment and prophylaxis of Pseudomonas aeruginosa infections of the bones. Denischi A, Meitert E, Cursaru A, Purghel E, Stăngulescu D, Sima F, Savulian C, Chersulick E, Petrescu AM, Costin M. Arch Roum Pathol Exp Microbiol; 1987; 46(2):111-27. PubMed ID: 3138966 [No Abstract] [Full Text] [Related]
2. Investigations on the efficacy of specific immunization with corpuscular vaccines in urinary tract infections with Pseudomonas aeruginosa or mixed bacteria. Neagu V, Meitert E, Ioanid CP, Racovită C, Găleşanu M, Sima F, Savulian C, Momiceanu D, Noica N, Neagoe M. Arch Roum Pathol Exp Microbiol; 1984; 43(1):39-52. PubMed ID: 6442131 [No Abstract] [Full Text] [Related]
3. Monovalent Pseudomonas aeruginosa vaccines in the treatment of otolaryngeal infections with Pseudomonas aeruginosa. Cincă D, Meitert E, Tomescu E, Meitert T, Suciu M, Sima F, Savulian C, Midan F, Lică I. Arch Roum Pathol Exp Microbiol; 1982; 41(3):277-84. PubMed ID: 6818930 [No Abstract] [Full Text] [Related]
4. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine. Ionescu A, Meitert E, Vasiliu S, Meitert T, Milicescu S, Sima F, Savulian C. Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594 [No Abstract] [Full Text] [Related]
6. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients. Ionescu A, Meitert E, Vasiliu S, Meitert T, Sima F, Savulian C, Milicescu S. Arch Roum Pathol Exp Microbiol; 1981; 40(4):323-32. PubMed ID: 6803737 [No Abstract] [Full Text] [Related]
7. Immunotherapy with monovalent Pseudomonas aeruginosa vaccine in chronic respiratory infections. Popescu C, Meitert E, Rusu R, Meitert T, Sima F, Savulian C. Arch Roum Pathol Exp Microbiol; 1982; 41(3):265-76. PubMed ID: 6818929 [No Abstract] [Full Text] [Related]
8. Determination of type specific IgG Pseudomonas antibodies by the ELISA test after administration of the anti Pseudomonas aeruginosa vaccine. Meitert T, Meitert E, Pencu E, Tonciu M. Arch Roum Pathol Exp Microbiol; 1984; 43(1):53-60. PubMed ID: 6442132 [No Abstract] [Full Text] [Related]
9. [Infection and host responses. (6) Evaluation of Pseudomonas vaccine therapy in refractory infection of the respiratory and transit areas]. Tanimoto H, Tachibana A. Nihon Naika Gakkai Zasshi; 1982 Oct 10; 71(10):1384-8. PubMed ID: 6820039 [No Abstract] [Full Text] [Related]
10. Mono--and polyvalent Pseudomonas aeruginosa vaccines. Preparation, control and administration. Meitert E, Meitert T, Sima F, Savulian C. Arch Roum Pathol Exp Microbiol; 1982 Oct 10; 41(2):105-14. PubMed ID: 6816188 [No Abstract] [Full Text] [Related]
11. [Use of Pseudomonas aeruginosa multicomponent vaccine in patients with intractable lower respiratory tract infection associated with diffuse panbronchiolitis]. Yoshimura K, Tachibana A, Nakatani T, Chonabayashi N, Nakamori Y, Nakata K, Tanimoto H. Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Jun 10; 24(6):625-32. PubMed ID: 3095578 [No Abstract] [Full Text] [Related]
12. [Clinical use of a Soviet polyvalent corpuscular pyocyanic vaccine for the prevention of Pseudomonas aeruginosa infection in thermal burn victims]. Gerasimova LI, Moroz AF, Radkevich SA, Sveshnikov AI, Mizikin EV. Khirurgiia (Mosk); 1980 Nov 10; (11):36-41. PubMed ID: 6777578 [No Abstract] [Full Text] [Related]
13. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients]. Nasiłowski W, Zietkiewicz W, Brudzyńska-Charewicz S, Bukowska D, Serafińska D, Rudowski W. Pol Tyg Lek; 1984 Apr 23; 39(17):557-61. PubMed ID: 6435103 [No Abstract] [Full Text] [Related]
14. [Complex treatment of pyocyanosis (review of the literature)]. Rozhavin MA, Sologub VV. Vrach Delo; 1981 Mar 23; (3):4-8. PubMed ID: 6794225 [No Abstract] [Full Text] [Related]
15. [Use of polyvalent vaccine against Pseudomonas aeruginosa in extensive burns]. Nasiłowski W, Zietkiewicz W, Brudzyńska-Charewicz S, Bukowska D, Serafińska D, Rudowski W. Pol Tyg Lek; 1981 Aug 10; 36(32):1207-11. PubMed ID: 6798556 [No Abstract] [Full Text] [Related]
16. Assessment of the effectiveness of antipseudomonas biological management in the control of infection in burn patients. Gonzáles Ayala SE, Daroda M, Villa J, Cecchini E, Vich J. Panminerva Med; 1983 Aug 10; 25(3):203-8. PubMed ID: 6422426 [No Abstract] [Full Text] [Related]
17. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin]. Moroz AF, Kharitonova AM, Chanturiia TsK. Antibiotiki; 1983 May 10; 28(5):341-5. PubMed ID: 6410985 [Abstract] [Full Text] [Related]
18. [Vaccine therapy against Pseudomonas aeruginosa]. Kurashige T, Tomoda T. Nihon Rinsho; 1991 Oct 10; 49(10):2421-4. PubMed ID: 1749099 [No Abstract] [Full Text] [Related]
19. [Immunogenic properties of a polyvalent vaccine against Pseudomonas aeruginosa]. Serafińska D, Bukowska D, Sokołowska K, Nasiłowski W. Pol Tyg Lek; 1980 Jul 07; 35(27):1013-5. PubMed ID: 6775310 [No Abstract] [Full Text] [Related]
20. [Our experience with the treatment of burns with sheep serum against Pseudomonas aeruginosa]. Orłowski T, Struzyna J, Badowski A, Schiller B, Kuntze A, Kozaczek W, Goller W. Wiad Lek; 1980 Nov 01; 33(21):1697-701. PubMed ID: 6784349 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]